Skip to main content
Corporate

CGS Associates, LLC

IVR: 866.238.9650
Customer Service and myCGS: 866.270.4909

LCD Tracking

Our LCD Tracking page allows you access to current and historical Local Coverage Determination (LCD) development-related information.

The Centers for Medicare and Medicaid Services (CMS) assigned to the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) the task of developing LCDs for processing and reviewing Medicare claims for Durable Medical Equipment, Prostheses, Orthoses, and Supplies (DMEPOS).

When the DME MACs receive a valid request to revise an existing LCD, or to develop a New LCD, we follow the LCD development process outlined in the Program Integrity Manual Chapter 13 (CMS Pub. 100-08).

The tables below provide you with up-to-date information on the LCDs under reconsideration or development. Check back frequently or sign up for the CGS listserv for the latest information.

Development Status: Open

LCD Type of Request: LCD Reconsideration or New LCD Details of Request Contractor Advisory Committee (CAC) Information (If Applicable) Proposed Local Coverage Determination Public Comment and Open Meeting Information Final Local Coverage Determination and Related Articles
Oxygen and Oxygen Equipment LCD Reconsideration Reconsideration request to add coverage for Topical Oxygen Therapy for wounds  
Urological Supplies LCD Reconsideration Reconsideration request to add coverage for inFlow™ N/A  
External Infusion Pumps LCD Reconsideration Reconsideration request to add coverage for Cutaquig® N/A  

Development Status: Completed

LCD Type of Request: LCD Reconsideration or New LCD Details of Request Contractor Advisory Committee (CAC) Information (If Applicable) Proposed Local Coverage Determination Public Comment and Open Meeting Information Final Local Coverage Determination and Related Articles
External Infusion Pumps LCD Reconsideration Reconsideration request to add coverage for Xembify® N/A
Nebulizers LCD Reconsideration Reconsideration request to add coverage for Yupelri® N/A
Tumor Treatment Field Therapy (TTFT) LCD Reconsideration Reconsideration request to add TTFT coverage for newly diagnosed glioblastoma multiforme

Updated: 06.01.20

Two Vantage Way, Nashville, TN 37228 © CGS Administrators, LLC. All Rights Reserved